ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

Henles to Get Bristol-Myers $25,000 Award

March 23, 1979

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

DCT Board Ok’s concept For In Vivo Combination Studies

November 23, 1990

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

Community Cancer Centers Selected For Pilot Program.

June 22, 2007

Olaparib Study Demonstrates No Changes In Overall Survival

March 30, 2012